3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Breast Neoplasms
19
Neoplasms
11
Polycystic Ovary Syndrome
9
Neoplasm Metastasis
4
Multiple Myeloma
4
Melanoma
4
Vomiting
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Solid Tumors
2
Skin Neoplasms
2
Sarcoma
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peripheral Nervous System Diseases
2
Ovarian Neoplasms
2
Obesity
2
Nausea
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Leukemia
2
Insulin Resistance
2
Inflammation
2
Diabetes Mellitus
2
Colorectal Neoplasms
2
Cognitive Dysfunction
2
Interventions
apixaban
18
Dalteparin
15
Rivaroxaban
11
Enoxaparin
10
Heparin, Low-Molecular-Weight
8
Aspirin
8
Tinzaparin
7
Warfarin
3
Fondaparinux
3
edoxaban
2
bemiparin
2
abelacimab
2
Rosuvastatin Calcium
2
Nadroparin
2
MAA868
2
Dabigatran
2
sotorasib
1
reviparin
1
isoquercitrin
1
enoxaparin sodium
1
certoparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
Tacrolimus
1
Tablets
1
Simvastatin
1
Platelet Transfusion
1
Phenprocoumon
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Venous Thromboembolism
×
Tablets
×
Clear all
NCT04243122
2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2
Completed
44 enrolled